-
1
-
-
0037975705
-
Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: Where do we go from here? A cumulative meta-analysis
-
Wardlaw JM, Sandercock PA, Berge E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke 2003;34:1437-42.
-
(2003)
Stroke
, vol.34
, pp. 1437-1442
-
-
Wardlaw, J.M.1
Sandercock, P.A.2
Berge, E.3
-
2
-
-
0035101902
-
Economic evaluation in stroke research. An introduction
-
Evers SM, Goossens ME, Ament AJ, et al. Economic evaluation in stroke research. An introduction. Cerebrovasc Dis 2001;11:82-91.
-
(2001)
Cerebrovasc Dis
, vol.11
, pp. 82-91
-
-
Evers, S.M.1
Goossens, M.E.2
Ament, A.J.3
-
3
-
-
0034094086
-
Economic evaluation in stroke research: A systematic review
-
Evers SM, Ament AJ, Blaauw G. Economic evaluation in stroke research: a systematic review. Stroke 2000;31:1046-53.
-
(2000)
Stroke
, vol.31
, pp. 1046-1053
-
-
Evers, S.M.1
Ament, A.J.2
Blaauw, G.3
-
4
-
-
0031946671
-
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
-
NINDS rt-PA Stroke Study Group
-
Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50:883-90.
-
(1998)
Neurology
, vol.50
, pp. 883-890
-
-
Fagan, S.C.1
Morgenstern, L.B.2
Petitta, A.3
-
5
-
-
0034798437
-
Cost-utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: A Canadian healthcare perspective
-
Sinclair SE, Frighetto L, Loewen PS, et al. Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective. Pharmacoeconomics 2001;19:927-36.
-
(2001)
Pharmacoeconomics
, vol.19
, pp. 927-936
-
-
Sinclair, S.E.1
Frighetto, L.2
Loewen, P.S.3
-
6
-
-
2542530145
-
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs
-
Sandercock P, Berge E, Dennis M, et al. Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs. Stroke 2004;35:1490-8.
-
(2004)
Stroke
, vol.35
, pp. 1490-1498
-
-
Sandercock, P.1
Berge, E.2
Dennis, M.3
-
7
-
-
0036434644
-
A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS
-
Sandercock P, Berge E, Dennis M, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess 2002;6:1-112.
-
(2002)
Health Technol Assess
, vol.6
, pp. 1-112
-
-
Sandercock, P.1
Berge, E.2
Dennis, M.3
-
8
-
-
84988905804
-
Thrombolysis for acute ischaemic stroke (Cochrane Review)
-
Oxford: Update Software
-
Wardlaw JM, del Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library. Oxford: Update Software, 2003:3.
-
(2003)
The Cochrane Library
, pp. 3
-
-
Wardlaw, J.M.1
Del Zoppo, G.2
Yamaguchi, T.3
-
9
-
-
2542562186
-
Editorial comment - What can models teach us about stroke treatment? Sorting out the missing bits
-
Matchar DB. Editorial comment - what can models teach us about stroke treatment? Sorting out the missing bits. Stroke 2004;35:1497-8.
-
(2004)
Stroke
, vol.35
, pp. 1497-1498
-
-
Matchar, D.B.1
-
10
-
-
0030840642
-
Modelling in economic evaluation: An unavoidable fact of life
-
Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997;6:217-27.
-
(1997)
Health Econ
, vol.6
, pp. 217-227
-
-
Buxton, M.J.1
Drummond, M.F.2
Van Hout, B.A.3
-
11
-
-
0029782690
-
The role of cost-effectiveness analysis in health and medicine
-
Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. JAMA 1996;276:1172-7.
-
(1996)
JAMA
, vol.276
, pp. 1172-1177
-
-
Russell, L.B.1
Gold, M.R.2
Siegel, J.E.3
-
12
-
-
0029794708
-
Recommendations of the panel on cost-effectiveness in health and medicine
-
Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8.
-
(1996)
JAMA
, vol.276
, pp. 1253-1258
-
-
Weinstein, M.C.1
Siegel, J.E.2
Gold, M.R.3
-
13
-
-
0029919387
-
Recommendations for reporting cost-effectiveness analyses
-
Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses. JAMA 1996;276:1339-41.
-
(1996)
JAMA
, vol.276
, pp. 1339-1341
-
-
Siegel, J.E.1
Weinstein, M.C.2
Russell, L.B.3
-
14
-
-
0030056579
-
Guidelines for authors and peer reviewers of economic submissions to the BMJ
-
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275-83.
-
(1996)
BMJ
, vol.313
, pp. 275-283
-
-
Drummond, M.F.1
Jefferson, T.O.2
-
15
-
-
0027772390
-
Markov models in medical decision making: A practical guide
-
Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-8.
-
(1993)
Med Decis Making
, vol.13
, pp. 322-328
-
-
Sonnenberg, F.A.1
Beck, J.R.2
-
17
-
-
0034982564
-
Utility of health states after stroke: A systematic review of the literature
-
Post PN, Stiggelbout AM, Wakker PP. Utility of health states after stroke: a systematic review of the literature. Stroke 2001;32:1425-9.
-
(2001)
Stroke
, vol.32
, pp. 1425-1429
-
-
Post, P.N.1
Stiggelbout, A.M.2
Wakker, P.P.3
-
18
-
-
0033798214
-
Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke?
-
Dorman P, Dennis MS, Sandercock P. Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? J Neurol Neurosurg Psychiatry 2000;69:487-93.
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.69
, pp. 487-493
-
-
Dorman, P.1
Dennis, M.S.2
Sandercock, P.3
-
19
-
-
0028133456
-
Patient preferences for stroke outcomes
-
Solomon NA, Glick HA, Russo CJ, et al. Patient preferences for stroke outcomes. Stroke 1994;25:1721-5.
-
(1994)
Stroke
, vol.25
, pp. 1721-1725
-
-
Solomon, N.A.1
Glick, H.A.2
Russo, C.J.3
-
20
-
-
0029060791
-
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
-
Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-24.
-
(1995)
N Engl J Med
, vol.332
, pp. 1418-1424
-
-
Mark, D.B.1
Hlatky, M.A.2
Califf, R.M.3
-
21
-
-
0033405959
-
A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke
-
Hallan S, Asberg A, Indredavik B, et al. A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke. J Intern Med 1999;246:549-59.
-
(1999)
J Intern Med
, vol.246
, pp. 549-559
-
-
Hallan, S.1
Asberg, A.2
Indredavik, B.3
-
22
-
-
0036217797
-
Development of a decision-analytic model of stroke care in the United States and Europe
-
Chambers MG, Koch P, Hutton J. Development of a decision-analytic model of stroke care in the United States and Europe. Value Health 2002;5:82-97.
-
(2002)
Value Health
, vol.5
, pp. 82-97
-
-
Chambers, M.G.1
Koch, P.2
Hutton, J.3
-
23
-
-
0033057012
-
A systematic review of cost-effectiveness research of stroke evaluation and treatment
-
Holloway RG, Benesch CG, Rahilly CR, et al. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke 1999;30:1340-9.
-
(1999)
Stroke
, vol.30
, pp. 1340-1349
-
-
Holloway, R.G.1
Benesch, C.G.2
Rahilly, C.R.3
-
24
-
-
0347986831
-
Editorial comment-stroke cost-effectiveness research: Are acceptability curves acceptable?
-
Holloway R, Dick AW. Editorial comment-stroke cost-effectiveness research: are acceptability curves acceptable? Stroke 2004;35:203-4.
-
(2004)
Stroke
, vol.35
, pp. 203-204
-
-
Holloway, R.1
Dick, A.W.2
-
25
-
-
0036844470
-
Prediction of length of stay of first-ever ischemic stroke
-
Chang KC, Tseng MC, Weng HH, et al. Prediction of length of stay of first-ever ischemic stroke. Stroke 2002;33:2670-4.
-
(2002)
Stroke
, vol.33
, pp. 2670-2674
-
-
Chang, K.C.1
Tseng, M.C.2
Weng, H.H.3
-
26
-
-
17444434925
-
Costs of acute care of first-ever ischemic stroke in Taiwan
-
Chang KC, Tseng MC. Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke 2003;34:e219-21.
-
(2003)
Stroke
, vol.34
-
-
Chang, K.C.1
Tseng, M.C.2
|